|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
National collaborating centre for cancer
(UK): Bladder cancer: Diagnosis and management, 2015.
|
|
3
|
Shariat SF, Karakiewicz PI, Palapattu GS,
Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ,
Sagalowsky AI, et al: Outcomes of radical cystectomy for
transitional cell carcinoma of the bladder: A contemporary series
from the Bladder Cancer Research Consortium. J Urol. 176:2414–2422.
2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hautmann RE, de Petriconi RC, Pfeiffer C
and Volkmer BG: Radical cystectomy for urothelial carcinoma of the
bladder without neoadjuvant or adjuvant therapy: Long-term results
in 1100 patients. Eur Urol. 61:1039–1047. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stein JP, Lieskovsky G, Cote R, Groshen S,
Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M,
et al: Radical cystectomy in the treatment of invasive bladder
cancer: Long-term results in 1,054 patients. J Clin Oncol.
19:666–675. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Canter D, Long C, Kutikov A, Plimack E,
Saad I, Oblaczynski M, Zhu F, Viterbo R, Chen DY, Uzzo RG, et al:
Clinicopathological outcomes after radical cystectomy for clinical
T2 urothelial carcinoma: Further evidence to support the use of
neoadjuvant chemotherapy. BJU Int. 107:58–62. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444.
2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Scott HR, McMillan DC, Forrest LM, Brown
DJ, McArdle CS and Milroy R: The systemic inflammatory response,
weight loss, performance status and survival in patients with
inoperable non-small cell lung cancer. Br J Cancer. 87:264–267.
2002.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kang M, Jeong CW, Kwak C, Kim HH and Ku
JH: Preoperative neutrophil-lymphocyte ratio can significantly
predict mortality outcomes in patients with non-muscle invasive
bladder cancer undergoing transurethral resection of bladder tumor.
Oncotarget. 8:12891–12901. 2016.
|
|
10
|
Omae K, Kondo T and Tanabe K: High
preoperative C-reactive protein values predict poor survival in
patients on chronic hemodialysis undergoing nephrectomy for renal
cancer. Urol Oncol. 33:e9–e13. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gunduz S, Mutlu H, Tural D, Yildiz O,
Uysal M, Coskun HS and Bozcuk H: Platelet to lymphocyte ratio as a
new prognostic for patients with metastatic renal cell cancer. Asia
Pac J Clin Oncol. 11:288–292. 2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yuksel OH, Akan S, Uukmez A, Yildirim C,
Sahin A and Verit A: Preoperative Glasgow prognostic score as a
predictor of primary bladder cancer recurrence. Mol Clin Oncol.
5:201–206. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Morgan TM, Tang D, Stratton KL, Barocas
DA, Anderson CB, Gregg JR, Chang SS, Cookson MS, Herrell SD, Smith
JA Jr and Clark PE: Preoperative nutritional status is an important
predictor of survival in patients undergoing surgery for renal cell
carcinoma. Eur Urol. 59:923–928. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhou T, Zhan J, Hong S, Hu Z, Fang W, Qin
T, Ma Y, Yang Y, He X, Zhao Y, et al: Ratio of C-reactive
protein/albumin is an inflammatory prognostic score for predicting
overall survival of patients with small-cell lung cancer. Sci Rep.
5(10481)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu X, Sun X, Liu J, Kong P, Chen S, Zhan
Y and Xu D: Preoperative C-reactive protein/albumin ratio predicts
prognosis of patients after curative resection for gastric cancer.
Transl Oncol. 8:339–345. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kinoshita A, Onoda H, Imai N, Iwaku A,
Oishi M, Tanaka K, Fushiya N, Koike K, Nishino H and Matsushima M:
The C-reactive protein/albumin ratio, a novel inflammation-based
prognostic score, predicts outcomes in patients with hepatocellular
carcinoma. Ann Surg Oncol. 22:803–810. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Morizawa Y, Miyake M, Shimada K, Hori S,
Tatsumi Y, Nakai Y, Anai S, Tanaka N, Konishi N and Fujimoto K:
Neutrophil-to-lymphocyte ratio as a detection marker of tumor
recurrence in patients with muscle-invasive bladder cancer after
radical cystectomy. Urol Oncol Semin Orig Investig. 34:257.e11–e17.
2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kang M, Jeong CW, Kwak C, Kim HH and Ku
JH: The prognostic significance of the early postoperative
neutrophil-to-lymphocyte ratio in patients with urothelial
carcinoma of the bladder undergoing radical cystectomy. Ann Surg
Oncol. 23:335–342. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Nishihara K, Suekane S, Ueda K, Nakiri M,
Matsuo M and Igawa T: High postoperative neutrophil-to-lymphocyte
ratio as a poorprognostic marker in patients with upper tract
urothelial carcinoma. Oncol Lett. 17:5241–5250. 2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Herr HW: Extent of pelvic lymph node
dissection during radical cystectomy: Where and Why! Eur Urol.
57:212–213. 2010.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ghoneim MA, Abdel-Latif M, El-Mekresh M,
Abol-Enein H, Mosbah A, Ashamallah A and El-Baz MA: Radical
cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5
years later. J Urol. 180:121–127. 2008.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Sobin L, Gospodarowicz M and Wittekind C:
TNM classification of malignant tumours, 7th edition, 2009.
|
|
23
|
John E, Guido S, Jonathan E and Isabell S:
Pathology and genetics: Tumours of the urinary system and male
genital system, 2004.
|
|
24
|
Imai E, Horio M, Nitta K, Yamagata K,
Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A and Matsuo S:
Modification of the modification of diet in renal disease (MDRD)
Study equation for Japan. Am J Kidney Dis. 50:927–937.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shen Y, Wang H, Li W and Chen J:
Prognostic significance of the CRP/Alb and neutrophil to lymphocyte
ratios in hepatocellular carcinoma patients undergoing TACE and
RFA. J Clin Lab Anal. 33(e22999)2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Utz DC, Hanash KA and Farrow GM: The
plight of the patient with carcinoma in situ of the bladder. J
Urol. 103:160–164. 1970.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Stanisic TH, Donovan JM, Lebouton J and
Graham AR: 5-Year experience with intravesical therapy of carcinoma
in situ: An inquiry into the risks of ‘conservative’ management. J
Urol. 138:1158–1161. 1987.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lamm D, Herr H, Jakse G, Kuroda M, Mostofi
FK, Okajima E, Sakamoto A, Sesterhenn I and da Silva FC: Updated
concepts and treatment of carcinoma in situ. Urol Oncol. 4:130–138.
1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Uemura K, Kawahara T, Yamashita D, Jikuya
R, Abe K, Tatenuma T, Yokomizo Y, Izumi K, Teranishi JI, Makiyama
K, et al: Neutrophil-to-lymphocyte ratio predicts prognosis in
castration-resistant prostate cancer patients who received
cabazitaxel chemotherapy. Biomed Res Int.
2017(7538647)2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kasuga J, Kawahara T, Takamoto D, Fukui S,
Tokita T, Tadenuma T, Narahara M, Fusayasu S, Terao H, Izumi K, et
al: Increased neutrophil-to-lymphocyte ratio is associated with
disease-specific mortality in patients with penile cancer. BMC
Cancer. 16(396)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Tanaka N, Kikuchi E, Shirotake S, Kanao K,
Matsumoto K, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, et
al: The predictive value of C-reactive protein for prognosis in
patients with upper tract urothelial carcinoma treated with radical
nephroureterectomy: A multi-institutional study. Eur Urol.
65:227–234. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tanaka H, Tamura T, Toyokawa T, Muguruma
K, Miki Y, Kubo N, Sakurai K, Hirakawa K and Ohira M: Clinical
relevance of postoperative neutrophil-lymphocyte ratio (NLR) to
recurrence after adjuvant chemotherapy of S-1 for gastric cancer.
Anticancer Res. 38:3745–3751. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Jin F, Han A, Shi F, Kong L and Yu J: The
postoperative neutrophil-to-lymphocyte ratio and changes in this
ratio predict survival after the complete resection of stage I
non-small cell lung cancer. Onco Targets Ther. 9:6529–6537.
2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Albisinni S, Moussa I, Aoun F, Quackels T,
Assenmacher G, Peltier A and Roumeguère T: The impact of
postoperative inflammatory biomarkers on oncologic outcomes of
bladder cancer. Prog Urol. 29:270–281. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Obermair A, Simunovic M, Isenring L and
Janda M: Nutrition interventions in patients with gynecological
cancers requiring surgery. Gynecol Oncol. 145:192–199.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ballmer PE, Ochsenbein AF and
Schütz-Hofmann S: Transcapillary escape rate of albumin positively
correlates with plasma albumin concentration in acute but not in
chronic inflammatory disease. Metabolism. 43:697–705.
1994.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Xiao Y, Ren YK, Cheng HJ, Wang L and Luo
SX: Modified Glasgow prognostic score is an independent prognostic
factor in patients with cervical cancer undergoing
chemoradiotherapy. Int J Clin Exp Pathol. 8:5273–5281.
2015.PubMed/NCBI
|
|
38
|
Ayhan A, Günakan E, Alyazıcı İ, Haberal N,
Altundağ Ö and Dursun P: The preoperative albumin level is an
independent prognostic factor for optimally debulked epithelial
ovarian cancer. Arch Gynecol Obstet. 296:989–995. 2017.PubMed/NCBI View Article : Google Scholar
|
